Optimal cutoff levels of more sensitive cardiac troponin assays for the early diagnosis of myocardial infarction in patients with renal dysfunction

Circulation

Volumn 131, Issue 23, 2015, Pages 2041-2050

  Twerenbold, Raphael ^a   Wildi, Karin ^a   Jaeger, Cedric ^a   Gimenez, Maria Rubini ^a,b   Reiter, Miriam ^a   Reichlin, Tobias ^a,c   Walukiewicz, Astrid ^a   Gugala, Mathias ^a   Krivoshei, Lian ^a   Marti, Nadine ^a   Moreno Weidmann, Zoraida ^a   Hillinger, Petra ^a   Puelacher, Christian ^a   Rentsch, Katharina ^a   Honegger, Ursina ^a   Schumacher, Carmela ^a   Zurbriggen, Felicitas ^a   Freese, Michael ^a   Stelzig, Claudia ^a   Campodarve, Isabel ^b   Bassetti, Stefano ^a   Osswald, Stefan ^a   Mueller, Christian ^a   more..

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

High sensitivity; Kidney; Myocardial infarction; Renal insufficiency; Troponin

Indexed keywords

TROPONIN; BIOLOGICAL MARKER; TROPONIN I; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ASSAY; CARDIOLOGIST; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOASSAY ANALYZER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; DIAGNOSTIC TEST; FOLLOW UP; INTERNATIONAL COOPERATION; KIDNEY; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS; DIAGNOSTIC TESTS, ROUTINE; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INTERNATIONAL COOPERATION; KIDNEY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; REFERENCE VALUES; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TROPONIN I; TROPONIN T;

EID: 84935473393     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.014245     Document Type: Article

References (38)

1. Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR, Casey DE Jr, Ettinger SM, Fesmire FM, Ganiats TG, Lincoff AM, Peterson ED, Philippides GJ, Theroux P, Wenger NK, Zidar JP, Anderson JL; 2012 Writing Committee Members; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2012;126: 875-910. doi: 10.1161/CIR.0b013e318256f1e0.
2. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, Wijns W, Zahger D; ESC Committee for Practice Guidelines. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32: 2999-3054. doi: 10.1093/eurheartj/ehr236.
3. O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso JE, Tracy CM, Woo YJ, Zhao DX; Force CAT. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: Executive summary : A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127: 529-555.
4. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, Van der Wall EE, Bassand JP, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfinkel EP, Lopez-Sendon JL, Pais P, Mendis S, Zhu JR, Wallentin LC, Fernández-Avilés F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio-Pulkki LM, Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Morais J, Brener S, Harrington R, Morrow D, Lim M, Martinez-Rios MA, Steinhubl S, Levine GN, Gibler WB, Goff D, Tubaro M, Dudek D, Al-Attar N; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Circulation. 2007;116: 2634-2653. doi: 10.1161/CIRCULATIONAHA.107.187397.
5. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC Jr; 2011 Writing Group Members; ACCF/AHA Task Force Members. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;123: E426-e579. doi: 10.1161/CIR.0b013e318212bb8b.
6. Forberg JL, Henriksen LS, Edenbrandt L, Ekelund U. Direct hospital costs of chest pain patients attending the emergency department: A retrospective study. BMC Emerg Med. 2006;6: 6. doi: 10.1186/1471-227X-6-6.
7. Tiemann O. Variations in hospitalisation costs for acute myocardial infarction: A comparison across Europe. Health Econ. 2008;17(suppl): S33-S45. doi: 10.1002/hec.1322.
8. Pines JM, Pollack CV Jr, Diercks DB, Chang AM, Shofer FS, Hollander JE. The association between emergency department crowding and adverse cardiovascular outcomes in patients with chest pain. Acad Emerg Med. 2009;16: 617-625. doi: 10.1111/j.1553-2712.2009.00456.x.
9. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351: 1296-1305. doi: 10.1056/NEJMoa041031.
10. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351: 1285-1295. doi: 10.1056/NEJMoa041365.
11. Aronow WS, Ahn C, Mercando AD, Epstein S. Prevalence of coronary artery disease, complex ventricular arrhythmias, and silent myocardial ischemia and incidence of new coronary events in older persons with chronic renal insufficiency and with normal renal function. Am J Cardiol. 2000;86: 1142-1143, A9.
12. Nakamura S, Uzu T, Inenaga T, Kimura G. Prediction of coronary artery disease and cardiac events using electrocardiographic changes during hemodialysis. Am J Kidney Dis. 2000;36: 592-599. doi: 10.1053/ajkd.2000.16198.
13. Apple FS, Jesse RL, Newby LK, Wu AH, Christenson RH; National Academy of Clinical Biochemistry; IFCC Committee for Standardization of Markers of Cardiac Damage. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage laboratory medicine practice guidelines: Analytical issues for biochemical markers of acute coronary syndromes. Circulation. 2007;115: E352-e355. doi: 10.1161/CIRCULATIONAHA.107.182881.
14. Apple FS, Smith SW, Pearce LA, Ler R, Murakami MM. Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem. 2008;54: 723-728. doi: 10.1373/clinchem.2007.097162.
15. Melanson SE, Morrow DA, Jarolim P. Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. Am J Clin Pathol. 2007;128: 282-286. doi: 10.1309/Q9W5HJTT24GQCXXX.
16. Apple FS. A new season for cardiac troponin assays: It's time to keep a scorecard. Clin Chem. 2009;55: 1303-1306. doi: 10.1373/clinchem.2009.128363.
17. Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, Bickel C, Baldus S, Warnholtz A, Fröhlich M, Sinning CR, Eleftheriadis MS, Wild PS, Schnabel RB, Lubos E, Jachmann N, Genth-Zotz S, Post F, Nicaud V, Tiret L, Lackner KJ, Münzel TF, Blankenberg S. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med. 2009;361: 868-877. doi: 10.1056/NEJMoa0903515.
18. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, Biedert S, Schaub N, Buerge C, Potocki M, Noveanu M, Breidthardt T, Twerenbold R, Winkler K, Bingisser R, Mueller C. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009;361: 858-867. doi: 10.1056/NEJMoa0900428.
19. Flores-Solís LM, Hernández-Domínguez JL. Cardiac troponin I in patients with chronic kidney disease stage 3 to 5 in conditions other than acute coronary syndrome. Clin Lab. 2014;60: 281-290.
20. Chen S, Huang C, Wu B, Lian X, Mei X, Wan J. Cardiac troponin I in nonacute coronary syndrome patients with chronic kidney disease. PLoS One. 2013;8: E82752. doi: 10.1371/journal.pone.0082752.
21. Pfortmueller CA, Funk GC, Marti G, Leichtle AB, Fiedler GM, Schwarz C, Exadaktylos AK, Lindner G. Diagnostic performance of highsensitive troponin T in patients with renal insufficiency. Am J Cardiol. 2013;112: 1968-1972. doi: 10.1016/j.amjcard.2013.08.028.
22. Reichlin T, Irfan A, Twerenbold R, Reiter M, Hochholzer W, Burkhalter H, Bassetti S, Steuer S, Winkler K, Peter F, Meissner J, Haaf P, Potocki M, Drexler B, Osswald S, Mueller C. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation. 2011;124: 136-145. doi: 10.1161/CIRCULATIONAHA.111.023937.
23. Reiter M, Twerenbold R, Reichlin T, Haaf P, Peter F, Meissner J, Hochholzer W, Stelzig C, Freese M, Heinisch C, Breidthardt T, Freidank H, Winkler K, Campodarve I, Gea J, Mueller C. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J. 2011;32: 1379-1389. doi: 10.1093/eurheartj/ehr033.
24. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation: Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130: 461-470.
25. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G; National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med. 2003;139: 137-147.
26. Levey AS. Clinical practice: Nondiabetic kidney disease. N Engl J Med. 2002;347: 1505-1511. doi: 10.1056/NEJMcp013462.
27. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J. 2007;28: 2525-2538. doi: 10.1093/eurheartj/ehm355.
28. Apple FS, Wu AH, Jaffe AS. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trials. Am Heart J. 2002;144: 981-986. doi: 10.1067/mhj.2002.124048.
29. Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA, Tjora S, Domanski MJ, Gersh BJ, Rouleau JL, Pfeffer MA, Braunwald E; Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial Investigators. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med. 2009;361: 2538-2547. doi: 10.1056/NEJMoa0805299.
30. Eggers KM, Lagerqvist B, Venge P, Wallentin L, Lindahl B. Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality. Circulation. 2007;116: 1907-1914. doi: 10.1161/CIRCULATIONAHA.107.708529.
31. Michos ED, Wilson LM, Yeh HC, Berger Z, Suarez-Cuervo C, Stacy SR, Bass EB. Prognostic value of cardiac troponin in patients with chronic kidney disease without suspected acute coronary syndrome: A systematic review and meta-analysis. Ann Intern Med. 2014;161: 491-501. doi: 10.7326/M14-0743.
32. Stacy SR, Suarez-Cuervo C, Berger Z, Wilson LM, Yeh HC, Bass EB, Michos ED. Role of troponin in patients with chronic kidney disease and suspected acute coronary syndrome: A systematic review. Ann Intern Med. 2014;161: 502-512. doi: 10.7326/M14-0746.
33. Maisel AS, Clopton P, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Steg G, Westheim A, Knudsen CW, Perez A, Kazanegra R, Bhalla V, Herrmann HC, Aumont MC, McCullough PA; BNP Multinational Study Investigators. Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: Results from the Breathing Not Properly (BNP) multinational study. Am Heart J. 2004;147: 1078-1084. doi: 10.1016/j.ahj.2004.01.013.
34. Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, Pfisterer M, Perruchoud AP. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med. 2004;350: 647-654. doi: 10.1056/NEJMoa031681.
35. Christ-Crain M, Stolz D, Bingisser R, Müller C, Miedinger D, Huber PR, Zimmerli W, Harbarth S, Tamm M, Müller B. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: A randomized trial. Am J Respir Crit Care Med. 2006;174: 84-93. doi: 10.1164/rccm.200512-1922OC.
36. Gore MO, Seliger SL, Defilippi CR, Nambi V, Christenson RH, Hashim IA, Hoogeveen RC, Ayers CR, Sun W, McGuire DK, Ballantyne CM, de Lemos JA. Age-and sex-dependent upper reference limits for the highsensitivity cardiac troponin T assay. J Am Coll Cardiol. 2014;63: 1441-1448. doi: 10.1016/j.jacc.2013.12.032.
37. Sandoval Y, Apple FS. The global need to define normality: The 99th percentile value of cardiac troponin. Clin Chem. 2014;60: 455-462. doi: 10.1373/clinchem.2013.211706.
38. Artunc F, Mueller C, Breidthardt T, Twerenbold R, Peter A, Thamer C, Weyrich P, Haering HU, Friedrich B. Sensitive troponins: Which suits better for hemodialysis patients? Associated factors and prediction of mortality. PLoS One. 2012;7: E47610. doi: 10.1371/journal.pone.0047610.